License: Creative Commons License Open Access by Alzheimers & Parkinsons Disease: Open Access is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at SciRes Literature..

Manuscript should be submitted in Word Document (.doc or .docx) through online form or can be mailed to the particular journal's E-mail ID or to submit@scireslit.com, scireslit@gmail.com

Review Articles

Articles

We publish a wide range of article types in the Medical and Clinical Groups.

Our Vision

SciRes Literature main aim is to enhance the importance of science and technology to the scientific community and also to provide an equal opportunity to seek and share ideas to all our researchers and scientists without any barriers to develop their career and helping in their development of discovering the world.

Author Feedback

Amit Kumar

Amit Kumar

Weill Medical College of Cornell University, USA

Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.
Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.
Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.
Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.
 

  Authors submit all Proposals and manuscripts via Electronic Form! Submit a Manuscript!